IL-8 and IFN-γ in Tear Fluid of Patients with Cystic Fibrosis

2006 ◽  
Vol 26 (2) ◽  
pp. 71-75 ◽  
Author(s):  
Malgorzata Mrugacz ◽  
Maciej Kaczmarski ◽  
Alina Bakunowicz-Lazarczyk, ◽  
Beata Zelazowska ◽  
Jolanta Wysocka ◽  
...  
Keyword(s):  
PLoS ONE ◽  
2014 ◽  
Vol 9 (5) ◽  
pp. e96681 ◽  
Author(s):  
Kaivon Assani ◽  
Mia F. Tazi ◽  
Amal O. Amer ◽  
Benjamin T. Kopp

PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0213092
Author(s):  
Kaivon Assani ◽  
Mia F. Tazi ◽  
Amal O. Amer ◽  
Benjamin T. Kopp

2020 ◽  
Vol 8 (9) ◽  
pp. 1407
Author(s):  
Margherita Degasperi ◽  
Chiara Agostinis ◽  
Mario Mardirossian ◽  
Massimo Maschio ◽  
Andrea Taddio ◽  
...  

Most Cystic Fibrosis (CF) patients succumb to airway inflammation and pulmonary infections due to Pseudomonas aeruginosa. D-BMAP18, a membrane-permeabilizing antimicrobial peptide composed of D-amino acids, was evaluated as a possible antibacterial aimed to address this issue. The antipseudomonal activity of D-BMAP18 was tested in a pathophysiological context. The peptide displayed activity against CF isolates of Pseudomonas aeruginosa in the presence of CF sputum when combined with sodium chloride and DNase I. In combination with DNase I, D-BMAP18 discouraged the deposition of new biofilm and eradicated preformed biofilms of some P. aeruginosa strains. In addition, D-BMAP18 down regulated the production of TNF-α, IL1-β, and TGF-β in LPS-stimulated or IFN-γ macrophages derived from THP-1 cells indicating an anti-inflammatory activity. The biocompatibility of D-BMAP18 was assessed using four different cell lines, showing that residual cell-specific cytotoxicity at bactericidal concentrations could be abolished by the presence of CF sputum. Overall, this study suggests that D-BMAP18 may be an interesting molecule as a starting point to develop a novel therapeutic agent to simultaneously contrast lung infections and inflammation in CF patients.


2007 ◽  
Vol 27 (6) ◽  
pp. 491-496 ◽  
Author(s):  
Malgorzata Mrugacz ◽  
Beata Zelazowska ◽  
Alina Bakunowicz-Lazarczyk ◽  
Maciej Kaczmarski ◽  
Jolanta Wysocka

2020 ◽  
Vol 6 (4) ◽  
pp. 00590-2020
Author(s):  
Milou M.F. Schuurbiers ◽  
Mariolina Bruno ◽  
Sanne M.H. Zweijpfenning ◽  
Cecile Magis-Escurra ◽  
Martin Boeree ◽  
...  

The prevalence of Mycobacterium abscessus infections in non-cystic fibrosis (CF) patients has increased in recent years. In this study, we investigate whether immune defects explain the apparent susceptibility to this opportunistic infection in non-CF patients.We performed stimulations of peripheral blood mononuclear cells and whole blood from 13 patients with M. abscessus pulmonary disease and 13 healthy controls to investigate their cytokine production after 24 h and 7 days.Patients were predominantly women (54%) with a mean age of 59 years; 62% had nodular bronchiectatic disease. Many patients had predisposing pulmonary diseases, such as COPD (46%), and asthma (23%). Patients with COPD showed an impaired interleukin (IL)-6 response to M. abscessus and a reduced IL-17 response to Candida, together with a M. abscessus-specific enhanced IL-22 production. Patients without COPD showed higher levels of interleukin-1 receptor antagonist (IL-1Ra), an anti-inflammatory molecule. Within the non-COPD patients, those with bronchiectasis showed defective interferon (IFN)-γ production in response to Candida albicans.In conclusion, susceptibility to M. abscessus is likely determined by a combination of immunological defects and predisposing pulmonary disease. The main defect in the innate immune response was a shift of the ratio of IL-1β to IL-1Ra, which decreased the bioactivity of this pathway in the adaptive immune response. In the adaptive immune response there was defective IL-17 and IFN-γ production. Patients with COPD and bronchiectasis showed different cytokine defects. It is therefore crucial to interpret the immunological results within the clinical background of the patients tested.


2003 ◽  
Vol 4 (1) ◽  
Author(s):  
Salvador Raga ◽  
M Rosa Julià ◽  
Catalina Crespí ◽  
Joan Figuerola ◽  
Natalia Martínez ◽  
...  

2004 ◽  
Vol 287 (2) ◽  
pp. L374-L381 ◽  
Author(s):  
Shuo Zheng ◽  
Weiling Xu ◽  
Santanu Bose ◽  
Amiya K. Banerjee ◽  
S. Jaharul Haque ◽  
...  

Cystic fibrosis (CF) airway epithelial cells are more susceptible to viral infection due to impairment of the innate host defense pathway of nitric oxide (NO). NO synthase-2 (NOS2) expression is absent, and signal transducer and activator of transcription (STAT) 1 activation is reduced in CF. We hypothesized that the IFN-γ signaling pathway, which leads to NOS2 gene induction in CF airway epithelial cells, is defective. In contrast to a lack of NOS2 induction, the major histocompatibility complex class 2, an IFN-γ-regulated delayed-responsive gene, is similarly induced in CF and non-CF airway epithelial (NL) cells, suggesting an NOS2-specific defect in the IFN-γ signaling pathway. STAT1 and activator protein-1, both required for NOS2 gene expression, interact normally in CF cells. Protein inhibitor of activated STAT1 is not increased in CF cells. IFN-γ induces NOS2 expression in airway epithelial cells through an autocrine mechanism involving synthesis and secretion of IFN-γ-inducible mediator(s), which activates STAT1. Here, CF cells secrete IFN-γ-inducible factor(s), which stimulate NOS2 expression in NL cells, but not in CF cells. In contrast, IFN-γ-inducible factor(s) similarly inhibit virus in CF and NL cells. Thus autocrine activation of NOS2 is defective in CF cells, but IFN-γ induction of antiviral host defense is intact.


JAMA ◽  
1966 ◽  
Vol 195 (12) ◽  
pp. 993-1000 ◽  
Author(s):  
R. J. Grand
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document